Generate Biomedicines (GENB) Director Frances Arnold Sells 1,000 Shares

What Happened Frances Arnold, a director of Generate Biomedicines, sold 1,000 shares of GENB stock in an open-market transaction on September 1, 2026. The reported weighted-average price was $16.00 per share (prices ranged $16.00–$16.01), for total proceeds of approximately $16,002. This was a sale (not a purchase or option exercise).

Key Details

• Transaction date: 2026-09-01; Filing date: 2026-09-03 (Form 4 accession 0001193125-26-381875).
• Shares sold: 1,000; Weighted-average price reported: $16.00; price range: $16.00–$16.01; proceeds ≈ $16,002.
• Shares owned after transaction: Not disclosed in this filing.
• Footnotes of note:
  • F1: Sale effected pursuant to a Rule 10b5-1 trading plan adopted March 13, 2026.
  • F2: Weighted-average price reflects multiple trades; reporter can provide per-price breakdown on request.
  • F3: Reporting person disclaims beneficial ownership for purposes of Section 16 except to the extent of any pecuniary interest.
• Timeliness: No late filing indicated (transaction reported on Form 4 filed Sept 3, 2026).

Context The sale was made under a pre-established 10b5-1 trading plan, which typically means the transactions were scheduled in advance and are often considered routine rather than an immediate signal of insider sentiment. As with all insider filings, this is factual reporting of transactions and does not state the insider's motives.